Targeting LAG‐3 restores CD8+ T cell effector function through CD94/NKG2‐Qa‐1b signaling

Targeting LAG‐3 restores CD8+ T cell effector function through CD94/NKG2‐Qa‐1b signaling

Saved in:

Bibliographic Details
Main Authors:	Zhiqiang Wang, Mingzhu Yin, Ge Lou
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	MedComm – Oncology
Online Access:	https://doi.org/10.1002/mog2.70003
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
by: Chiara Giordano, et al.
Published: (2025-01-01)

NKG2C+CD57+ Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8+ T Cell Evolution towards Senescence
by: John Heath, et al.
Published: (2016-01-01)

SLAMF7 defines subsets of human effector CD8 T cells
by: Hassen Kared, et al.
Published: (2024-12-01)

Effector, Memory, and Dysfunctional CD8+ T Cell Fates in the Antitumor Immune Response
by: John Reiser, et al.
Published: (2016-01-01)

Protein Phosphatase 2A Promotes CD8+ T Cell Effector Function through the Augmentation of CD28 Costimulation
by: Kaixiang Zhu, et al.
Published: (2025-01-01)

CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
by: Xin Jin, et al.
Published: (2023-12-01)

Serial Assessment of Immune Status by Circulating CD8+ Effector T Cell Frequencies for Posttransplant Infectious Complications
by: Shinji Uemoto, et al.
Published: (2008-01-01)

Novel approach to alleviate lupus nephritis: targeting the NLRP3 inflammasome in CD8+CD69+CD103+ TRM cells
by: Yimei Lai, et al.
Published: (2024-12-01)

Anti-CD122 antibody restores specific CD8+ T cell response in nonalcoholic steatohepatitis and prevents hepatocellular carcinoma growth
by: Stéphanie Lacotte, et al.
Published: (2023-12-01)

INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses
by: Jason Ho, et al.
Published: (2023-01-01)

CD3+CD8+CD28− T Lymphocytes in Patients with Lupus Nephritis
by: Marcelina Żabińska, et al.
Published: (2016-01-01)

Retracted: Role of CD4+T, CD8+T Cells, and CD4+T/CD8+T Cell Ratio in Gastric Cancer and Its Clinical Significance
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
by: Rawaa AlChalabi, et al.
Published: (2025-01-01)

Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study
by: Tatsuo Itou, et al.
Published: (2024-12-01)

Flt3L enhances clonal diversification and selective expansion of intratumoral CD8+ T cells while differentiating into effector-like cells
by: Dongmin Chun, et al.
Published: (2024-12-01)

Ex Vivo Restimulation of Human PBMC Expands a CD3+CD4-CD8-γδ+ T Cell Population That Can Confound the Evaluation of CD4 and CD8 T Cell Responses to Vaccination
by: B. J. Sedgmen, et al.
Published: (2013-01-01)

Establishment of Normal Reference Intervals for CD3+, CD4+, CD8+, and CD4+ to CD8+ Ratio of T Lymphocytes in HIV Negative Adults from University of Gondar Hospital, North West Ethiopia
by: Addisu Gize, et al.
Published: (2014-01-01)

Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer
by: Jun Yu, et al.
Published: (2024-03-01)

eEF-2K Deficiency Boosts the Virus-Specific Effector CD8<sup>+</sup> T Cell Responses During Viral Infection
by: Liqing Wang, et al.
Published: (2024-12-01)

Immunogenic clearance combined with PD-1 blockade elicits antitumor effect by promoting the recruitment and expansion of the effector memory-like CD8+ T cell
by: Seong A Kim, et al.
Published: (2025-01-01)

Deficiencies of Inducible Costimulator (ICOS) During Chronic Infection with <i>Toxoplasma gondii</i> Upregulate the CD28-Dependent Cytotoxicity of CD8<sup>+</sup> T Cells and Their Effector Function Against Tissue Cysts of the Parasite
by: Rajesh Mani, et al.
Published: (2024-12-01)

Correlation of Interleukin-17-Producing Effector Memory T Cells and CD4+CD25+Foxp3 Regulatory T Cells with the Phosphate Levels in Chronic Hemodialysis Patients
by: Cheng-Lin Lang, et al.
Published: (2014-01-01)

CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
by: Yi Sun, et al.
Published: (2025-01-01)

Suppressed Programmed Death 1 Expression on CD4+ and CD8+ T Cells in Psoriatic Patients
by: Joanna Bartosińska, et al.
Published: (2017-01-01)

CD4+T and CD8+T Cells in Uterus Exhibit Both Selective Dysfunction and Residency Signatures
by: Shuangpeng Kang, et al.
Published: (2024-01-01)

Sézary Syndrome with CD4/CD8 Double-Negative Neoplastic T Cells in Peripheral Blood
by: Yuki Kageyama, et al.
Published: (2021-01-01)

CD69+CD103+CD8+ tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer
by: Zi-Xin Wu, et al.
Published: (2024-12-01)

Enabling immune checkpoint blockade efficacy in T-lymphopenia by restoring CD8 T cell dynamics with IL-7 cytokine therapy
by: Yeon-Woo Kang, et al.
Published: (2024-12-01)

Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
by: Gui-Qi Zhu, et al.
Published: (2025-01-01)

CD38 as theranostic target in oncology
by: Valentina Bocuzzi, et al.
Published: (2024-11-01)

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML
by: Patrick Schlegel, et al.
Published: (2015-01-01)

SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein
by: Simone Parn, et al.
Published: (2022-12-01)

Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
by: Daciana C. Dumut, et al.
Published: (2025-02-01)

T CD3+CD8+ Lymphocytes Are More Susceptible for Apoptosis in the First Trimester of Normal Human Pregnancy
by: Dorota Darmochwal-Kolarz, et al.
Published: (2014-01-01)

The Effects of Aloe vera Cream on the Expression of CD4+ and CD8+ Lymphocytes in Skin Wound Healing
by: Yos Adi Prakoso, et al.
Published: (2018-01-01)

Serum levels of soluble IL-2R, CD4 and CD8 in bronChial asthma
by: G. Di Lorenzo, et al.
Published: (1995-01-01)

Circulating CD3+CD8+ T Lymphocytes as Indicators of Disease Status in Patients With Early Breast Cancer
by: Han‐Kun Chen, et al.
Published: (2025-01-01)

Key role of CD4+ T cells in determining CD8 function during CAR-T cell manufacture
by: J Joseph Melenhorst, et al.
Published: (2024-03-01)

The Glycopeptide PV-PS A1 Immunogen Elicits Both CD4+ and CD8+ Responses
by: Sharmeen Nishat, et al.
Published: (2024-12-01)

Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3+CD8+CD56+ Natural Killer T Population in Women with Recurrent Spontaneous Abortion
by: Fatemeh Rezayat, et al.
Published: (2023-07-01)